About
Kevin Starr co-architected a company-creation-first model that incubates academic science through 1–3-year scientist collaborations, building companies focused on ultra-rare and orphan diseases using gene therapy and precision oncology.
Invests in
BiotechHealthtechMedical Devices
Deals · 3
Decibel Therapeutics, Inc.Board seat
via Third Rock Ventures · filed Jan 2017 · $57.8M raise
Afferent PharmaceuticalsBoard seat
via Third Rock Ventures · filed Jul 2015 · $55M raise
MyokardiaBoard seat
via Third Rock Ventures · filed Apr 2015 · $46M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Third Rock Ventures
Abbie Celniker
Investor at Third Rock Ventures
Adam Tebbe
Investor at Third Rock Ventures
Alan Ezekowitz
Investor at Third Rock Ventures
Alison Connors
Investor at Third Rock Ventures
Amanda Chan
Investor at Third Rock Ventures
Andrea van Elsas
Investor at Third Rock Ventures
Andrew Warren
Senior Associate at Third Rock Ventures
Angelo Severino
Investor at Third Rock Ventures